Tumour sections stained with Ki67 and pRb revealed a significant reduction of both Ki67-positive cells and pRb-positive cells in tumours following intrapulmonary administration of P2shortA combined with Abemaciclib, indicative of a reduced proliferative index and reduced CDK4 activity, respectively (Figure 7E-G). This evidence concerns the gene CDK4 and neoplasm.